Unit 3 Micro: Glaxo SmithKline fined $3 billion for off-label marketing
The scale of the fine is staggering, Glaxo SmithKline has been found guilty of off-label marketing - an illegal strategy - GSK targeted the antidepressant Paxil at patients under age 18 when it was approved only for adults, and promoted the drug Wellbutrin for uses it was not approved for, including weight loss and treatment of sexual dysfunction
This is corporate irresponsibility on a grand scale as this new report makes clear.
More From the Digital Store
A comprehensive collection of editable lesson topic worksheets to support the teaching of the core teaching content Year 1 (AS) A Level Economics specification.
A comprehensive series of topic-by-topic study notes to support students on Section 1 (Microeconomics) of the IB Diploma in Economics. It covers both the SL and HL content of the IB...
Much cheaper & more effective than TES or the Guardian. Reach the audience you really want to apply for your teaching vacancy by posting directly to our website and related social media audiences.